8.91
+0.27(+3.13%)
Currency In USD
| Previous Close | 8.64 |
| Open | 8.64 |
| Day High | 9.27 |
| Day Low | 8.64 |
| 52-Week High | 47.45 |
| 52-Week Low | 6.36 |
| Volume | 3.13M |
| Average Volume | 2.88M |
| Market Cap | 1.26B |
| PE | -2.47 |
| EPS | -3.61 |
| Moving Average 50 Days | 11.45 |
| Moving Average 200 Days | 18.55 |
| Change | 0.27 |
If you invested $1000 in Dyne Therapeutics, Inc. (DYN) since IPO date, it would be worth $372.8 as of July 14, 2025 at a share price of $8.91. Whereas If you bought $1000 worth of Dyne Therapeutics, Inc. (DYN) shares 3 years ago, it would be worth $904.57 as of July 14, 2025 at a share price of $8.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
GlobeNewswire Inc.
Jul 02, 2025 8:01 PM GMT
WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the clos
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
GlobeNewswire Inc.
Jul 01, 2025 1:45 AM GMT
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pri
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Jun 30, 2025 8:05 PM GMT
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it